Unknown

Dataset Information

0

In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model.


ABSTRACT: Synthetically engineered DNA-encoded monoclonal antibodies (DMAbs) are an in vivo platform for evaluation and delivery of human mAb to control against infectious disease. Here, we engineer DMAbs encoding potent anti-Zaire ebolavirus (EBOV) glycoprotein (GP) mAbs isolated from Ebola virus disease survivors. We demonstrate the development of a human IgG1 DMAb platform for in vivo EBOV-GP mAb delivery and evaluation in a mouse model. Using this approach, we show that DMAb-11 and DMAb-34 exhibit functional and molecular profiles comparable to recombinant mAb, have a wide window of expression, and provide rapid protection against lethal mouse-adapted EBOV challenge. The DMAb platform represents a simple, rapid, and reproducible approach for evaluating the activity of mAb during clinical development. DMAbs have the potential to be a mAb delivery system, which may be advantageous for protection against highly pathogenic infectious diseases, like EBOV, in resource-limited and other challenging settings.

SUBMITTER: Patel A 

PROVIDER: S-EPMC6319964 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7211204 | biostudies-literature
| S-EPMC3257937 | biostudies-literature
| S-EPMC6239932 | biostudies-literature
| S-EPMC4702560 | biostudies-literature
| S-EPMC6994112 | biostudies-literature
| S-EPMC4201348 | biostudies-literature
| S-EPMC5829823 | biostudies-literature
| S-EPMC8040518 | biostudies-literature
| S-EPMC2446956 | biostudies-literature
| S-EPMC6520333 | biostudies-literature